Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference
- Aug 15, 2019
- 2 min
Leaders in Recruitment Tech Aim to Combat Bias in Machine Learning by 2021
- Aug 15, 2019
- 5 min
Weyland Tech Reports Q2 2019 Results; Recurring Revenue up 53% to $7.1 Million
- Aug 14, 2019
- 3 min
Soliton Treats First Patients in Pivotal Cellulite Trial
- Aug 12, 2019
- 3 min
Soliton Announces Patient Recruitment Has Begun for Pivotal Cellulite Trial
- Aug 6, 2019
- 3 min
Moleculin Announces Breakthrough Discovery: WP1066 Potentially Capable of Immune Reprogramming in
- Aug 6, 2019
- 3 min
Soliton Completes Site Enrollment & Conducts Initial Site Training to Start Pivotal Cellulite Trial
- Aug 5, 2019
- 3 min
Soliton Partners with Clear Dermatology and Aesthetics Center to Advance Pivotal Cellulite Trial
- Aug 1, 2019
- 3 min
Soliton Announces Global Nasdaq Partner Sanmina Delivers RAP Device to More Effectively Target
- Jul 31, 2019
- 9 min
Avalon Forms A Colossal Partnership
- Jul 29, 2019
- 3 min
Soliton Announces IRB Approval
- Jul 29, 2019
- 3 min
CEO of Weyland Tech, Brent Suen, Discusses the Opportunity in Southeast Asia on the Fintech Wave
- Jul 25, 2019
- 3 min
Soliton Enlists Chicago Cosmetic Surgery and Dermatology to Advance Pivotal Cellulite Trial
- Jul 23, 2019
- 3 min
Soliton's FDA Cleared Device is Granted Key Patent
- Jul 22, 2019
- 4 min
Avalon GloboCare and GE Healthcare Announce Strategic Partnership
- Jul 18, 2019
- 4 min
Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort
- Jul 16, 2019
- 3 min
Soliton Announces Submission for IRB Approval of Pivotal Cellulite Trial Protocol
- Jul 16, 2019
- 3 min
Weyland Tech Inc. Launches Food Delivery Service in Indonesia with AtozGo
- Jul 15, 2019
- 5 min
Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate LongTerm Improvement
- Jul 15, 2019
- 4 min
Avalon GloboCare Provides Updates on its Lead Clinical Programs in CAR-T Therapy